Picton Mahoney Asset Management Acquires Shares of 200,735 Pfizer Inc. $PFE

NodeGuardian · 2026-03-06T04:00:34+00:00

Picton Mahoney Asset Management acquired 200,735 shares in Pfizer, valued at $5.12 million. Pfizer's strong Q4 results and dividend announcement contrast with mixed analyst sentiments, reflecting a "Hold" rating and a price target of $28.05.

NodeGuardian

2026-03-06 04:00:34

Abstract generation in progress

Picton Mahoney Asset Management has acquired a new stake of 200,735 shares in Pfizer Inc. (NYSE:PFE) during the third quarter, valued at approximately $5.12 million. This comes as Pfizer reported strong Q4 results, beating EPS and revenue expectations, and announced a quarterly dividend of $0.43. While institutional ownership is around 68.36%, analyst sentiment is mixed, with an average “Hold” rating and a price target of $28.05, despite some positive developments in its pipeline, oncology, and AI integration.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.